The role of a master regulator of EMT most convincingly has been demonstrated by the ability of GRHL2 to significantly impede transforming growth factor β- or Twist-induced and spontaneous EMT in breast cancer cells (4, 6). Here, GRHL2 is linked to breast carcinoma.